TNSN06292A1 - Use of renin inhibitors in therapy - Google Patents
Use of renin inhibitors in therapyInfo
- Publication number
- TNSN06292A1 TNSN06292A1 TNP2006000292A TNSN06292A TNSN06292A1 TN SN06292 A1 TNSN06292 A1 TN SN06292A1 TN P2006000292 A TNP2006000292 A TN P2006000292A TN SN06292 A TNSN06292 A TN SN06292A TN SN06292 A1 TNSN06292 A1 TN SN06292A1
- Authority
- TN
- Tunisia
- Prior art keywords
- hypertension
- restenosis
- syndrome
- therapy
- renoprotection
- Prior art date
Links
Abstract
The present is directed to a method for the prevention of, delay progression to or treatment of a condition or disease selected from diabetes type 2 (associated with or without hypertension), severe hypertension, PH, malignant hypertension, isolated systolic hypertension, familial dyslipidemic hypertension, endothelial dysfunction (with or without hypertension), survival post-MI, increase of formation of collagen and other extracellular matrix proteins, restenosis after stenting, PVD including PAD and peripheral venous disorders, CAD, morbidity, mortality, cerebrovascular diseases, metabolic disorder (Syndrome X), AF, renoprotection, reduction of proteinuria, renal failure, glomerulonephritis, nephrotic syndrome, renal fibrosis, AIN, ATN, acute tubulo-interstitial nephritis, PKD, vascular inflammation, rennin secreting tumors, vasculitides or closure, restenosis of dialysis access grafts comprising administering a compound of formula (I) or a pharmaceutically acceptable salt thereof alone or in combination with another active ingredient.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US55387704P | 2004-03-17 | 2004-03-17 | |
| PCT/EP2005/002809 WO2005089731A2 (en) | 2004-03-17 | 2005-03-16 | Use of renin inhibitors in therapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TNSN06292A1 true TNSN06292A1 (en) | 2007-12-03 |
Family
ID=37879285
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TNP2006000292A TNSN06292A1 (en) | 2004-03-17 | 2006-09-15 | Use of renin inhibitors in therapy |
Country Status (3)
| Country | Link |
|---|---|
| CN (1) | CN1933823A (en) |
| TN (1) | TNSN06292A1 (en) |
| ZA (1) | ZA200607239B (en) |
-
2005
- 2005-03-16 CN CN 200580008590 patent/CN1933823A/en active Pending
-
2006
- 2006-08-30 ZA ZA200607239A patent/ZA200607239B/en unknown
- 2006-09-15 TN TNP2006000292A patent/TNSN06292A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1933823A (en) | 2007-03-21 |
| ZA200607239B (en) | 2008-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG153831A1 (en) | Use of renin inhibitors in therapy | |
| WO2006037031A3 (en) | Formulations and methods for treatment of inflammatory diseases | |
| WO2005117954A3 (en) | Compositions and methods for treatment of neovascular diseases | |
| WO2007126964A3 (en) | Kinase inhibitors | |
| WO2004069201A3 (en) | Compounds useful in coating stents to prevent and treat stenosis and restenosis | |
| MX2008013836A (en) | 2-pyridone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial. | |
| JPH10279482A (en) | Use of pyrimidine derivative alone or in combination with other therapeutic method for preventing cancer | |
| EP1807086A1 (en) | Use of dipyridamole in combination with antithrombotics for treatment and prevention of thromboembolic diseases | |
| JP6507336B2 (en) | Treatment of liver fibrosis using CBP / catenin inhibitors | |
| RU2008102249A (en) | PREVENTIVE OR THERAPEUTIC AGENT FOR CORNEAL / CONJUNCTIVE DISEASE | |
| Takai et al. | New approaches to blockade of the renin–angiotensin–aldosterone system: chymase as an important target to prevent organ damage | |
| EP1192949A4 (en) | Preventive or therapeutic drugs for fibrosis containing chymase inhibitors as the active ingredient | |
| CN102099039A (en) | Use of pyrimidylaminobenzamide derivatives for the treatment of fibrosis | |
| ES2704229T3 (en) | Selective AT2 receptor agonists for use in the treatment of cachexia | |
| EP1780212A4 (en) | PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVE | |
| TNSN06292A1 (en) | Use of renin inhibitors in therapy | |
| AU2004212305A1 (en) | Use of dipyridamole in combination with acetylsalicylic acid and an angiotensin II antagonist for stroke prevention | |
| AU739148B2 (en) | Treatment of skin disorders | |
| Yuri et al. | Effects of pipemidic acid, phenazopyridine HCl and sodium diclofenac on pain perception following endoscopic urological surgery: double-blinded randomized-controlled trial | |
| EP2908820A1 (en) | Treatment of pulmonary fibrosis using an inhibitor of cbp/catenin | |
| IL112125A (en) | Quinazolinone-containing pharmaceutical compositions | |
| Okada et al. | Combination therapy with angiotensin-converting enzyme inhibitor and oral adsorbent of uremic toxins can delay the appearance of glomerular sclerosis and interstitial fibrosis in established renal failure | |
| AU2002366975B2 (en) | Quinazolinone compounds in combined modalities for improved cancer treatment | |
| WO2004045380A3 (en) | Compositions containing an active fraction isolated from tannins and methods of use | |
| NZ535199A (en) | Use of an inhibitor or antagonist against tissue factor |